Patent · US Active

Compositions comprising MIR34 therapeutic agents for treating cancer

US8378088B2 · kind B2 · utility

3Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 5, 2008
Grant dateFeb 19, 2013
Priority date
Expiry dateAug 1, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/178
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

In one aspect, the invention generally relates to compositions comprising miR-34 and siRNAs functionally and structurally related to miR-34 for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.